AtonRa Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,967
Closed -$510K 127
2022
Q4
$510K Sell
3,967
-1,456
-27% -$188K 0.65% 68
2022
Q3
$742K Buy
5,423
+87
+2% +$14.2K 0.73% 63
2022
Q2
$944K Sell
5,336
-1,740
-25% -$251K 0.87% 44
2022
Q1
$1.02M Sell
7,076
-1,886
-21% -$255K 0.55% 74
2021
Q4
$1.39M Buy
8,962
+960
+12% +$161K 0.48% 74
2021
Q3
$1.36M Buy
8,002
+732
+10% +$114K 0.45% 83
2021
Q2
$1.15M Buy
7,270
+812
+13% +$121K 0.42% 84
2021
Q1
$897K Buy
6,458
+1,146
+22% +$185K 0.4% 95
2020
Q4
$930K Buy
+5,312
New +$990K 0.46% 70

Other funds holding SGEN

AtonRa Partners's SGEN Position: Q1 2023 in Review

AtonRa Partners sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 3,967 shares — an estimated $510K sold.

AtonRa Partners first reported a position in SGEN in Q4 2020 and held it in 9 quarters. The position peaked at $1.39M in Q4 2021. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

  • AtonRa Partners reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • AtonRa Partners sold 3,967 Seagen Inc. Common Stock shares in Q1 2023, an estimated $510K.
  • AtonRa Partners first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • AtonRa Partners's Seagen Inc. Common Stock position peaked at $1.39M in Q4 2021.
  • 575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on AtonRa Partners's 13F filing for Q1 2023, filed 5 May 2023.